These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 3581712)

  • 1. A comparison of 3 and 6 weeks' anticoagulation in the treatment of venous thromboembolism.
    Fennerty AG; Dolben J; Thomas P; Backhouse G; Bentley DP; Campbell IA; Routledge PA
    Clin Lab Haematol; 1987; 9(1):17-21. PubMed ID: 3581712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimum duration of anticoagulation for deep-vein thrombosis and pulmonary embolism. Research Committee of the British Thoracic Society.
    Lancet; 1992 Oct; 340(8824):873-6. PubMed ID: 1357297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparin and warfarin: use of anticoagulants in the prevention and treatment of venous thrombosis and pulmonary embolism.
    Rosen RL
    J Fam Pract; 1979 May; 8(5):923-7. PubMed ID: 438753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathophysiology and treatment of deep-vein thrombosis and pulmonary embolism.
    Carter BL; Jones ME; Waickman LA
    Clin Pharm; 1985; 4(3):279-96. PubMed ID: 3891200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. The Duration of Anticoagulation Trial Study Group.
    Schulman S; Granqvist S; Holmström M; Carlsson A; Lindmarker P; Nicol P; Eklund SG; Nordlander S; Lärfars G; Leijd B; Linder O; Loogna E
    N Engl J Med; 1997 Feb; 336(6):393-8. PubMed ID: 9010144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current concepts of anticoagulation therapy.
    Hull RD; Pineo GF
    Clin Chest Med; 1995 Jun; 16(2):269-80. PubMed ID: 7656539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent pulmonary embolism in patients treated because of acute venous thromboembolism: a prospective study.
    Monreal M; Lafoz E; Ruiz J; Callejas JM; Arias A
    Eur J Vasc Surg; 1994 Sep; 8(5):584-9. PubMed ID: 7813725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of warfarin started early after submassive venous thrombosis or pulmonary embolism.
    Gallus A; Jackaman J; Tillett J; Mills W; Wycherley A
    Lancet; 1986 Dec; 2(8519):1293-6. PubMed ID: 2878173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticoagulation for three versus six months in patients with deep vein thrombosis or pulmonary embolism, or both: randomised trial.
    Campbell IA; Bentley DP; Prescott RJ; Routledge PA; Shetty HG; Williamson IJ
    BMJ; 2007 Mar; 334(7595):674. PubMed ID: 17289685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of established deep vein thrombosis: a review of the therapeutic armamentarium.
    Berkowitz SD
    Orthopedics; 1995 Jul; 18 Suppl():18-20. PubMed ID: 7479421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of venous thrombosis and pulmonary embolism.
    Kakkar V
    Am J Cardiol; 1990 Feb; 65(6):50C-54C. PubMed ID: 2405627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis.
    Levine MN; Hirsh J; Gent M; Turpie AG; Weitz J; Ginsberg J; Geerts W; LeClerc J; Neemeh J; Powers P
    Thromb Haemost; 1995 Aug; 74(2):606-11. PubMed ID: 8584992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Audit of anticoagulant therapy of pulmonary embolus, deep vein thrombosis and thrombophlebitis.
    Meinhold JM; Reale EO; Miller WA
    Am J Hosp Pharm; 1979 Feb; 36(2):214-8. PubMed ID: 420210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency of major hemorrhage in patients treated with unfractionated intravenous heparin for deep venous thrombosis or pulmonary embolism: a study in routine clinical practice.
    Zidane M; Schram MT; Planken EW; Molendijk WH; Rosendaal FR; van der Meer FJ; Huisman MV
    Arch Intern Med; 2000 Aug 14-28; 160(15):2369-73. PubMed ID: 10927736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of venous thromboembolic disease. A pragmatic approach to anticoagulation and thrombolysis.
    Linn BJ; Mazza JJ; Friedenberg WR
    Postgrad Med; 1986 May; 79(6):171-80. PubMed ID: 3703754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deep venous thrombosis. Implications after open heart surgery.
    DeLaria GA; Hunter JA
    Chest; 1991 Feb; 99(2):284-8. PubMed ID: 1989784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of venous thromboembolism.
    Lancet; 1988 Feb; 1(8580):275-7. PubMed ID: 2893086
    [No Abstract]   [Full Text] [Related]  

  • 18. The efficacy of low-dose heparin--warfarin anticoagulation prophylaxis after total hip replacement arthroplasty.
    Goss TP; Stinchfield FE; Cosgriff SW
    Clin Orthop Relat Res; 1979 Jun; (141):134-7. PubMed ID: 477094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current management of acute symptomatic deep vein thrombosis.
    Heit JA
    Am J Cardiovasc Drugs; 2001; 1(1):45-50. PubMed ID: 14728051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low molecular weight heparin versus warfarin in the prevention of recurrences after deep vein thrombosis.
    Pini M; Aiello S; Manotti C; Pattacini C; Quintavalla R; Poli T; Tagliaferri A; Dettori AG
    Thromb Haemost; 1994 Aug; 72(2):191-7. PubMed ID: 7831650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.